StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio – Wall Street Journal
|
StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
Wall Street Journal The portfolio broadly claims the manufacture and proliferation of purified populations of human neural stem cells and their use as therapeutics and as tools for drug discovery. The acquisition relieves the Company of all milestone and royalty … |
